Loading…
Evaluation of Distribution Patterns for Copper and Zinc in Metallothionein and Superoxide Dismutase in Chronic Liver Diseases and Hepatocellular Carcinoma Using High-Performance Liquid Chromatography (HPLC)
It has been reported that the copper (Cu) content of hepatocytes increases in chronic liver diseases and small hepatocellular carcinoma (HCC). In cells, Cu exists mainly as Cu-metallothionein (MT) or Cu, zinc (Zn)-superoxide dismutase (SOD). In this study, we investigated the biochemical state of Cu...
Saved in:
Published in: | Biological & Pharmaceutical Bulletin 2005, Vol.28(7), pp.1137-1141 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c733t-c2b2f78b649982ca70e868def06b57ed71f1d262eabecf53fdc1a0512ca390233 |
---|---|
cites | cdi_FETCH-LOGICAL-c733t-c2b2f78b649982ca70e868def06b57ed71f1d262eabecf53fdc1a0512ca390233 |
container_end_page | 1141 |
container_issue | 7 |
container_start_page | 1137 |
container_title | Biological & Pharmaceutical Bulletin |
container_volume | 28 |
creator | Kubo, Satoshi Fukuda, Hiroyuki Ebara, Masaaki Ikota, Nobuo Saisho, Hiromitsu Nakagawa, Hidehiko Ozawa, Toshihiko Yukawa, Masae Kato, Kazuki Satoh, Tsunenobu Watayo, Takaho Sakurai, Hiromu |
description | It has been reported that the copper (Cu) content of hepatocytes increases in chronic liver diseases and small hepatocellular carcinoma (HCC). In cells, Cu exists mainly as Cu-metallothionein (MT) or Cu, zinc (Zn)-superoxide dismutase (SOD). In this study, we investigated the biochemical state of Cu in the hepatocytes of patients with HCC using high-performance liquid chromatography (HPLC). The subjects of present study were 23 patients with HCC who underwent liver resection. The cancerous tissue and non-cancerous hepatic parenchyma with chronic disease were analyzed. In addition, as a normal control, hepatic tissue was collected at autopsy from 13 patients with no liver disease. Each sample was diluted with buffer, chilled, homogenized, and centrifuged. The supernatant was fractionated using HPLC. The metal contents of each fraction were measured using a desktop-type inductively coupled plasma (ICP) emission spectrochemical analyzer. HPLC analysis showed that MT existed mainly as Zn-MT in the normal hepatic tissue. The case of Cu,Zn-MT was significantly greater than Zn-MT in the non-cancerous, but diseased hepatic parenchyma than in the normal hepatic tissue (p |
doi_str_mv | 10.1248/bpb.28.1137 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68001944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3121282171</sourcerecordid><originalsourceid>FETCH-LOGICAL-c733t-c2b2f78b649982ca70e868def06b57ed71f1d262eabecf53fdc1a0512ca390233</originalsourceid><addsrcrecordid>eNpdkV2L1DAUhoso7rp65b0EBFGkYz7aJr1TxnVHGHFA98abkKanMxnapJuki_sn_U2mM7MueJMQ3uc857Qny14SvCC0EB-asVlQsSCE8UfZOWEFz0tKysfZOa6JyCtSirPsWQh7jDHHlD3NzkhZ1xyL6jz7c3mr-klF4yxyHfpsQvSmmQ7vjYoRvA2ocx4t3TiCR8q26JexGhmLvkFUfe_iLsGQ3nP2Y0qU-21amF3DFFWAmV3uvLNGo7W5TZYUQQrCoWQFo4pOQ99PvUqNlNfGukGh62DsFq3MdpdvwKchBmU1JMXNZNqDcUiFW6_G3R16u9qsl--eZ0861Qd4cbovsusvlz-Xq3z9_err8tM615yxmGva0I6LpirqWlCtOAZRiRY6XDUlh5aTjrS0oqAa0F3JulYThUuSUFanX8gusjdH7-jdzQQhysGE-ROUBTcFWQmMSV0UCXz9H7h3k7dpNkmKomZFRQqcqPdHSnsXgodOjt4Myt9JguW8ZJmWLKmQ85IT_erknJoB2gf2tNUEXB2BlBqtemd7Y-Ghsw68Ma53kmJcSoypwDxd5KBPR0EI5qzms-nj0bQPUW3hXyvlo9E93I_Fj8eh_D7SO-UlWPYXrg7T4Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1449346140</pqid></control><display><type>article</type><title>Evaluation of Distribution Patterns for Copper and Zinc in Metallothionein and Superoxide Dismutase in Chronic Liver Diseases and Hepatocellular Carcinoma Using High-Performance Liquid Chromatography (HPLC)</title><source>Full-Text Journals in Chemistry (Open access)</source><creator>Kubo, Satoshi ; Fukuda, Hiroyuki ; Ebara, Masaaki ; Ikota, Nobuo ; Saisho, Hiromitsu ; Nakagawa, Hidehiko ; Ozawa, Toshihiko ; Yukawa, Masae ; Kato, Kazuki ; Satoh, Tsunenobu ; Watayo, Takaho ; Sakurai, Hiromu</creator><creatorcontrib>Kubo, Satoshi ; Fukuda, Hiroyuki ; Ebara, Masaaki ; Ikota, Nobuo ; Saisho, Hiromitsu ; Nakagawa, Hidehiko ; Ozawa, Toshihiko ; Yukawa, Masae ; Kato, Kazuki ; Satoh, Tsunenobu ; Watayo, Takaho ; Sakurai, Hiromu ; School of Medicine ; dDepartment of Surgery ; cThe Second Department of Pathology ; Chiba University ; Kyoto Pharmaceutical University ; bNational Institute of Radiological Sciences ; eDepartment of Analytical and Bioinorganic Chemistry ; aFirst Department of Medicine ; Tokyo Metropolitan Ebara Hospital</creatorcontrib><description>It has been reported that the copper (Cu) content of hepatocytes increases in chronic liver diseases and small hepatocellular carcinoma (HCC). In cells, Cu exists mainly as Cu-metallothionein (MT) or Cu, zinc (Zn)-superoxide dismutase (SOD). In this study, we investigated the biochemical state of Cu in the hepatocytes of patients with HCC using high-performance liquid chromatography (HPLC). The subjects of present study were 23 patients with HCC who underwent liver resection. The cancerous tissue and non-cancerous hepatic parenchyma with chronic disease were analyzed. In addition, as a normal control, hepatic tissue was collected at autopsy from 13 patients with no liver disease. Each sample was diluted with buffer, chilled, homogenized, and centrifuged. The supernatant was fractionated using HPLC. The metal contents of each fraction were measured using a desktop-type inductively coupled plasma (ICP) emission spectrochemical analyzer. HPLC analysis showed that MT existed mainly as Zn-MT in the normal hepatic tissue. The case of Cu,Zn-MT was significantly greater than Zn-MT in the non-cancerous, but diseased hepatic parenchyma than in the normal hepatic tissue (p<0.01). In comparison with non-cancerous hepatic parenchyma, the Cu-MT in the cancerous section was significantly greater than the Cu,Zn-MT (p<0.01). The Cu content for MT was significantly higher in small HCC (<40 mm) (p<0.01), and the absence of Cu or Zn in the MT fraction was significantly more frequent in the large HCC (≥40 mm) (p<0.01). The Cu and Zn content for SOD in the samples showed no significant difference. Increase in the Cu content in the cancerous hepatic tissue were, thought to be reflecting changes in the distribution of Cu in the MT fraction of hepatic tissues.</description><identifier>ISSN: 0918-6158</identifier><identifier>EISSN: 1347-5215</identifier><identifier>DOI: 10.1248/bpb.28.1137</identifier><identifier>PMID: 15997086</identifier><language>eng</language><publisher>Japan: The Pharmaceutical Society of Japan</publisher><subject>Aged ; Carcinoma, Hepatocellular - enzymology ; Carcinoma, Hepatocellular - metabolism ; Chromatography, High Pressure Liquid - methods ; Chronic Disease ; Copper - metabolism ; Female ; hepatocellular carcinoma ; high-performance liquid chromatography ; Humans ; Liver Neoplasms - enzymology ; Liver Neoplasms - metabolism ; Male ; metallothionein ; Metallothionein - chemistry ; Middle Aged ; particle-induced X-ray emission ; superoxide dismutase ; Superoxide Dismutase - metabolism ; Zinc - metabolism</subject><ispartof>Biological and Pharmaceutical Bulletin, 2005, Vol.28(7), pp.1137-1141</ispartof><rights>2005 The Pharmaceutical Society of Japan</rights><rights>Copyright Japan Science and Technology Agency 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c733t-c2b2f78b649982ca70e868def06b57ed71f1d262eabecf53fdc1a0512ca390233</citedby><cites>FETCH-LOGICAL-c733t-c2b2f78b649982ca70e868def06b57ed71f1d262eabecf53fdc1a0512ca390233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15997086$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kubo, Satoshi</creatorcontrib><creatorcontrib>Fukuda, Hiroyuki</creatorcontrib><creatorcontrib>Ebara, Masaaki</creatorcontrib><creatorcontrib>Ikota, Nobuo</creatorcontrib><creatorcontrib>Saisho, Hiromitsu</creatorcontrib><creatorcontrib>Nakagawa, Hidehiko</creatorcontrib><creatorcontrib>Ozawa, Toshihiko</creatorcontrib><creatorcontrib>Yukawa, Masae</creatorcontrib><creatorcontrib>Kato, Kazuki</creatorcontrib><creatorcontrib>Satoh, Tsunenobu</creatorcontrib><creatorcontrib>Watayo, Takaho</creatorcontrib><creatorcontrib>Sakurai, Hiromu</creatorcontrib><creatorcontrib>School of Medicine</creatorcontrib><creatorcontrib>dDepartment of Surgery</creatorcontrib><creatorcontrib>cThe Second Department of Pathology</creatorcontrib><creatorcontrib>Chiba University</creatorcontrib><creatorcontrib>Kyoto Pharmaceutical University</creatorcontrib><creatorcontrib>bNational Institute of Radiological Sciences</creatorcontrib><creatorcontrib>eDepartment of Analytical and Bioinorganic Chemistry</creatorcontrib><creatorcontrib>aFirst Department of Medicine</creatorcontrib><creatorcontrib>Tokyo Metropolitan Ebara Hospital</creatorcontrib><title>Evaluation of Distribution Patterns for Copper and Zinc in Metallothionein and Superoxide Dismutase in Chronic Liver Diseases and Hepatocellular Carcinoma Using High-Performance Liquid Chromatography (HPLC)</title><title>Biological & Pharmaceutical Bulletin</title><addtitle>Biol Pharm Bull</addtitle><description>It has been reported that the copper (Cu) content of hepatocytes increases in chronic liver diseases and small hepatocellular carcinoma (HCC). In cells, Cu exists mainly as Cu-metallothionein (MT) or Cu, zinc (Zn)-superoxide dismutase (SOD). In this study, we investigated the biochemical state of Cu in the hepatocytes of patients with HCC using high-performance liquid chromatography (HPLC). The subjects of present study were 23 patients with HCC who underwent liver resection. The cancerous tissue and non-cancerous hepatic parenchyma with chronic disease were analyzed. In addition, as a normal control, hepatic tissue was collected at autopsy from 13 patients with no liver disease. Each sample was diluted with buffer, chilled, homogenized, and centrifuged. The supernatant was fractionated using HPLC. The metal contents of each fraction were measured using a desktop-type inductively coupled plasma (ICP) emission spectrochemical analyzer. HPLC analysis showed that MT existed mainly as Zn-MT in the normal hepatic tissue. The case of Cu,Zn-MT was significantly greater than Zn-MT in the non-cancerous, but diseased hepatic parenchyma than in the normal hepatic tissue (p<0.01). In comparison with non-cancerous hepatic parenchyma, the Cu-MT in the cancerous section was significantly greater than the Cu,Zn-MT (p<0.01). The Cu content for MT was significantly higher in small HCC (<40 mm) (p<0.01), and the absence of Cu or Zn in the MT fraction was significantly more frequent in the large HCC (≥40 mm) (p<0.01). The Cu and Zn content for SOD in the samples showed no significant difference. Increase in the Cu content in the cancerous hepatic tissue were, thought to be reflecting changes in the distribution of Cu in the MT fraction of hepatic tissues.</description><subject>Aged</subject><subject>Carcinoma, Hepatocellular - enzymology</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Chronic Disease</subject><subject>Copper - metabolism</subject><subject>Female</subject><subject>hepatocellular carcinoma</subject><subject>high-performance liquid chromatography</subject><subject>Humans</subject><subject>Liver Neoplasms - enzymology</subject><subject>Liver Neoplasms - metabolism</subject><subject>Male</subject><subject>metallothionein</subject><subject>Metallothionein - chemistry</subject><subject>Middle Aged</subject><subject>particle-induced X-ray emission</subject><subject>superoxide dismutase</subject><subject>Superoxide Dismutase - metabolism</subject><subject>Zinc - metabolism</subject><issn>0918-6158</issn><issn>1347-5215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpdkV2L1DAUhoso7rp65b0EBFGkYz7aJr1TxnVHGHFA98abkKanMxnapJuki_sn_U2mM7MueJMQ3uc857Qny14SvCC0EB-asVlQsSCE8UfZOWEFz0tKysfZOa6JyCtSirPsWQh7jDHHlD3NzkhZ1xyL6jz7c3mr-klF4yxyHfpsQvSmmQ7vjYoRvA2ocx4t3TiCR8q26JexGhmLvkFUfe_iLsGQ3nP2Y0qU-21amF3DFFWAmV3uvLNGo7W5TZYUQQrCoWQFo4pOQ99PvUqNlNfGukGh62DsFq3MdpdvwKchBmU1JMXNZNqDcUiFW6_G3R16u9qsl--eZ0861Qd4cbovsusvlz-Xq3z9_err8tM615yxmGva0I6LpirqWlCtOAZRiRY6XDUlh5aTjrS0oqAa0F3JulYThUuSUFanX8gusjdH7-jdzQQhysGE-ROUBTcFWQmMSV0UCXz9H7h3k7dpNkmKomZFRQqcqPdHSnsXgodOjt4Myt9JguW8ZJmWLKmQ85IT_erknJoB2gf2tNUEXB2BlBqtemd7Y-Ghsw68Ma53kmJcSoypwDxd5KBPR0EI5qzms-nj0bQPUW3hXyvlo9E93I_Fj8eh_D7SO-UlWPYXrg7T4Q</recordid><startdate>20050701</startdate><enddate>20050701</enddate><creator>Kubo, Satoshi</creator><creator>Fukuda, Hiroyuki</creator><creator>Ebara, Masaaki</creator><creator>Ikota, Nobuo</creator><creator>Saisho, Hiromitsu</creator><creator>Nakagawa, Hidehiko</creator><creator>Ozawa, Toshihiko</creator><creator>Yukawa, Masae</creator><creator>Kato, Kazuki</creator><creator>Satoh, Tsunenobu</creator><creator>Watayo, Takaho</creator><creator>Sakurai, Hiromu</creator><general>The Pharmaceutical Society of Japan</general><general>Pharmaceutical Society of Japan</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050701</creationdate><title>Evaluation of Distribution Patterns for Copper and Zinc in Metallothionein and Superoxide Dismutase in Chronic Liver Diseases and Hepatocellular Carcinoma Using High-Performance Liquid Chromatography (HPLC)</title><author>Kubo, Satoshi ; Fukuda, Hiroyuki ; Ebara, Masaaki ; Ikota, Nobuo ; Saisho, Hiromitsu ; Nakagawa, Hidehiko ; Ozawa, Toshihiko ; Yukawa, Masae ; Kato, Kazuki ; Satoh, Tsunenobu ; Watayo, Takaho ; Sakurai, Hiromu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c733t-c2b2f78b649982ca70e868def06b57ed71f1d262eabecf53fdc1a0512ca390233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aged</topic><topic>Carcinoma, Hepatocellular - enzymology</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Chronic Disease</topic><topic>Copper - metabolism</topic><topic>Female</topic><topic>hepatocellular carcinoma</topic><topic>high-performance liquid chromatography</topic><topic>Humans</topic><topic>Liver Neoplasms - enzymology</topic><topic>Liver Neoplasms - metabolism</topic><topic>Male</topic><topic>metallothionein</topic><topic>Metallothionein - chemistry</topic><topic>Middle Aged</topic><topic>particle-induced X-ray emission</topic><topic>superoxide dismutase</topic><topic>Superoxide Dismutase - metabolism</topic><topic>Zinc - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kubo, Satoshi</creatorcontrib><creatorcontrib>Fukuda, Hiroyuki</creatorcontrib><creatorcontrib>Ebara, Masaaki</creatorcontrib><creatorcontrib>Ikota, Nobuo</creatorcontrib><creatorcontrib>Saisho, Hiromitsu</creatorcontrib><creatorcontrib>Nakagawa, Hidehiko</creatorcontrib><creatorcontrib>Ozawa, Toshihiko</creatorcontrib><creatorcontrib>Yukawa, Masae</creatorcontrib><creatorcontrib>Kato, Kazuki</creatorcontrib><creatorcontrib>Satoh, Tsunenobu</creatorcontrib><creatorcontrib>Watayo, Takaho</creatorcontrib><creatorcontrib>Sakurai, Hiromu</creatorcontrib><creatorcontrib>School of Medicine</creatorcontrib><creatorcontrib>dDepartment of Surgery</creatorcontrib><creatorcontrib>cThe Second Department of Pathology</creatorcontrib><creatorcontrib>Chiba University</creatorcontrib><creatorcontrib>Kyoto Pharmaceutical University</creatorcontrib><creatorcontrib>bNational Institute of Radiological Sciences</creatorcontrib><creatorcontrib>eDepartment of Analytical and Bioinorganic Chemistry</creatorcontrib><creatorcontrib>aFirst Department of Medicine</creatorcontrib><creatorcontrib>Tokyo Metropolitan Ebara Hospital</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biological & Pharmaceutical Bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kubo, Satoshi</au><au>Fukuda, Hiroyuki</au><au>Ebara, Masaaki</au><au>Ikota, Nobuo</au><au>Saisho, Hiromitsu</au><au>Nakagawa, Hidehiko</au><au>Ozawa, Toshihiko</au><au>Yukawa, Masae</au><au>Kato, Kazuki</au><au>Satoh, Tsunenobu</au><au>Watayo, Takaho</au><au>Sakurai, Hiromu</au><aucorp>School of Medicine</aucorp><aucorp>dDepartment of Surgery</aucorp><aucorp>cThe Second Department of Pathology</aucorp><aucorp>Chiba University</aucorp><aucorp>Kyoto Pharmaceutical University</aucorp><aucorp>bNational Institute of Radiological Sciences</aucorp><aucorp>eDepartment of Analytical and Bioinorganic Chemistry</aucorp><aucorp>aFirst Department of Medicine</aucorp><aucorp>Tokyo Metropolitan Ebara Hospital</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of Distribution Patterns for Copper and Zinc in Metallothionein and Superoxide Dismutase in Chronic Liver Diseases and Hepatocellular Carcinoma Using High-Performance Liquid Chromatography (HPLC)</atitle><jtitle>Biological & Pharmaceutical Bulletin</jtitle><addtitle>Biol Pharm Bull</addtitle><date>2005-07-01</date><risdate>2005</risdate><volume>28</volume><issue>7</issue><spage>1137</spage><epage>1141</epage><pages>1137-1141</pages><issn>0918-6158</issn><eissn>1347-5215</eissn><abstract>It has been reported that the copper (Cu) content of hepatocytes increases in chronic liver diseases and small hepatocellular carcinoma (HCC). In cells, Cu exists mainly as Cu-metallothionein (MT) or Cu, zinc (Zn)-superoxide dismutase (SOD). In this study, we investigated the biochemical state of Cu in the hepatocytes of patients with HCC using high-performance liquid chromatography (HPLC). The subjects of present study were 23 patients with HCC who underwent liver resection. The cancerous tissue and non-cancerous hepatic parenchyma with chronic disease were analyzed. In addition, as a normal control, hepatic tissue was collected at autopsy from 13 patients with no liver disease. Each sample was diluted with buffer, chilled, homogenized, and centrifuged. The supernatant was fractionated using HPLC. The metal contents of each fraction were measured using a desktop-type inductively coupled plasma (ICP) emission spectrochemical analyzer. HPLC analysis showed that MT existed mainly as Zn-MT in the normal hepatic tissue. The case of Cu,Zn-MT was significantly greater than Zn-MT in the non-cancerous, but diseased hepatic parenchyma than in the normal hepatic tissue (p<0.01). In comparison with non-cancerous hepatic parenchyma, the Cu-MT in the cancerous section was significantly greater than the Cu,Zn-MT (p<0.01). The Cu content for MT was significantly higher in small HCC (<40 mm) (p<0.01), and the absence of Cu or Zn in the MT fraction was significantly more frequent in the large HCC (≥40 mm) (p<0.01). The Cu and Zn content for SOD in the samples showed no significant difference. Increase in the Cu content in the cancerous hepatic tissue were, thought to be reflecting changes in the distribution of Cu in the MT fraction of hepatic tissues.</abstract><cop>Japan</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>15997086</pmid><doi>10.1248/bpb.28.1137</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0918-6158 |
ispartof | Biological and Pharmaceutical Bulletin, 2005, Vol.28(7), pp.1137-1141 |
issn | 0918-6158 1347-5215 |
language | eng |
recordid | cdi_proquest_miscellaneous_68001944 |
source | Full-Text Journals in Chemistry (Open access) |
subjects | Aged Carcinoma, Hepatocellular - enzymology Carcinoma, Hepatocellular - metabolism Chromatography, High Pressure Liquid - methods Chronic Disease Copper - metabolism Female hepatocellular carcinoma high-performance liquid chromatography Humans Liver Neoplasms - enzymology Liver Neoplasms - metabolism Male metallothionein Metallothionein - chemistry Middle Aged particle-induced X-ray emission superoxide dismutase Superoxide Dismutase - metabolism Zinc - metabolism |
title | Evaluation of Distribution Patterns for Copper and Zinc in Metallothionein and Superoxide Dismutase in Chronic Liver Diseases and Hepatocellular Carcinoma Using High-Performance Liquid Chromatography (HPLC) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T14%3A50%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20Distribution%20Patterns%20for%20Copper%20and%20Zinc%20in%20Metallothionein%20and%20Superoxide%20Dismutase%20in%20Chronic%20Liver%20Diseases%20and%20Hepatocellular%20Carcinoma%20Using%20High-Performance%20Liquid%20Chromatography%20(HPLC)&rft.jtitle=Biological%20&%20Pharmaceutical%20Bulletin&rft.au=Kubo,%20Satoshi&rft.aucorp=School%20of%20Medicine&rft.date=2005-07-01&rft.volume=28&rft.issue=7&rft.spage=1137&rft.epage=1141&rft.pages=1137-1141&rft.issn=0918-6158&rft.eissn=1347-5215&rft_id=info:doi/10.1248/bpb.28.1137&rft_dat=%3Cproquest_cross%3E3121282171%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c733t-c2b2f78b649982ca70e868def06b57ed71f1d262eabecf53fdc1a0512ca390233%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1449346140&rft_id=info:pmid/15997086&rfr_iscdi=true |